Surrozen Stock Quote SRZN - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

12.45

Bid

8.83

Ask

16.00

Volume

2,471

11.30 Day's Range 12.20

5.9999 52 Week Range 18.17

Market Cap

40.46M

Previous Close

11.787

Open

11.82

Last Trade

893

12.45

Last Trade Time

Financial Volume

$ 28,988

VWAP

11.7314

Average Volume (3m)

29,064

Shares Outstanding

3,249,798

Dividend Yield

PE Ratio

-0.92

Earnings Per Share (EPS)

-13.24

Revenue

Net Profit

-43.04M

Surrozen Inc is a class of therapeutics to treat serious diseases characterized by tissue injury. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), and SZN-043 (E3/ASGR1, SWEETS). Surrozen Inc is a class of therapeutics to treat serious diseases characterized by tissue injury. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), and SZN-043 (E3/ASGR1, SWEETS).

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.surrozen.com

Headquarters

Wilmington, Delaware, USA

Founded

Surrozen Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker SRZN. The last closing price for Surrozen was $11.79. Over the last year, Surrozen shares have traded in a share price range of $ 5.9999 to $ 18.17.

Surrozen currently has 3,249,798 shares outstanding. The market capitalization of Surrozen is $38.31 million. Surrozen has a price to earnings ratio (PE ratio) of -0.92.

FeaturedLaFleur Minerals Provides Update on Beacon Mill Restart, Results of Annual General and Special Meeting, and Swanson Gold Deposit Exploration and Drilling Updates

Surrozen to Present at Upcoming Healthcare Investor Conferences

SOUTH SAN FRANCISCO, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”...

Surrozen Provides Third Quarter 2024 Financial Results and Business Update

Substantial enrollment progress in Phase 1b trial of SZN-043 in severe alcohol-associated hepatitis patients...

Surrozen and TCGFB, Inc. Announce Strategic Research Collaboration to Develop TGF-β Antibodies for Idiopathic Pulmonary Fibrosis

SOUTH SAN FRANCISCO, Calif., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”...

Surrozen Earns $10 Million Milestone Payment in Retinal Diseases Collaboration

Boehringer is advancing the development of SZN-413 to prepare it for potential future clinical testing SZN-413...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Surrozen Provides Second Quarter 2024 Financial Results and Business Update

Enrollment ongoing in SZN-043 Phase 1b trial in patients with Severe Alcoholic Hepatitis Presented...

Surrozen Publishes Study in ‘eLife’ Demonstrating the Promise of The Proprietary SWEETS Platform, a Unique Targeted Protein Degradation Technology, to Further Enhance Wnt Signaling

Targeted protein degradation (TPD*) technologies have demonstrated the potential to produce novel treatment...

Surrozen Presents Preliminary Results from Phase 1a Study of SZN-043 in Healthy Volunteers and Patients with a History of Liver Cirrhosis at the 2024 European Association for the Study of the Liver (EASL) in Milan

SZN-043 is a novel biotherapeutic shown to potentiate Wnt signaling and induce proliferation of hepatocytes in...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.78	6.68380462725	11.67	12.2	10.5	2728	11.28975901	CS
4	1	8.73362445415	11.45	12.25	10.31	6460	11.33781313	CS
12	-2.8097	-18.4125507055	15.2597	18.17	9.5	29064	12.8564798	CS
26	3.55	39.8876404494	8.9	18.17	8.1	31034	11.53939279	CS
52	-1.95	-13.5416666667	14.4	18.17	5.9999	21667	11.01027809	CS
156	-32.55	-72.3333333333	45	55.95	4.5	141097	11.14241761	CS
260	-130.8	-91.3089005236	143.25	210	4.5	142019	30.4369383	CS

SRZN - Frequently Asked Questions (FAQ)

What is the current Surrozen share price?

The current share price of Surrozen is $ 12.45

How many Surrozen shares are in issue?

Surrozen has 3,249,798 shares in issue

What is the market cap of Surrozen?

The market capitalisation of Surrozen is USD 38.31M

What is the 1 year trading range for Surrozen share price?

Surrozen has traded in the range of $ 5.9999 to $ 18.17 during the past year

What is the PE ratio of Surrozen?

The price to earnings ratio of Surrozen is -0.92

What is the reporting currency for Surrozen?

Surrozen reports financial results in USD

What is the latest annual profit for Surrozen?

The latest annual profit of Surrozen is USD -43.04M

What is the registered address of Surrozen?

The registered address for Surrozen is CORPORATION TRUST CENTER 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801

What is the Surrozen website address?

The website address for Surrozen is www.surrozen.com

Which industry sector does Surrozen operate in?

Surrozen operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
SGLYSingularity Future Technology Ltd	$ 1.6799 (143.43%)	30.75M
WINVWinVest Acquisition Corporation	$ 25.00 (107.30%)	463
VVPRVivoPower International PLC	$ 1.2899 (52.13%)	65.08M
RNAZTransCode Therapeutics Inc	$ 1.12 (45.45%)	216.2M
GLTOGalecto Inc	$ 6.00 (44.93%)	10.71M
YHCLQR House Inc	$ 0.40 (-82.38%)	38.28M
KZIAKazia Therapeutics Ltd	$ 0.9759 (-80.02%)	55.66k
DMNDamon Inc	$ 0.0373 (-70.02%)	304.07M
TCBPTC BioPharm Holdings PLC	$ 0.5046 (-67.23%)	5.89M
SOWGSow Good Inc	$ 1.53 (-44.36%)	697.78k
DMNDamon Inc	$ 0.0373 (-70.02%)	304.07M
NVDANVIDIA Corporation	$ 117.70 (-0.70%)	264.41M
RNAZTransCode Therapeutics Inc	$ 1.12 (45.45%)	216.2M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	$ 9.03 (10.66%)	175.73M
HOLOMicroCloud Hologram Inc	$ 1.00 (32.36%)	141.95M